Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)
China flag China · Delayed Price · Currency is CNY
17.71
+0.46 (2.67%)
Nov 6, 2026, 9:25 AM CST

Wuhan Hvsen Biotechnology Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
1,7061,6811,2001,0201,023996.22
Revenue Growth
2.35%40.07%17.71%-0.31%2.68%28.14%
Gross Profit
581.51518.76194.72210.65222.75268.51
Operating Income
304.37279.4718.356.5761.01135.28
Net Income
324.09253.16-20.1616.7852.71132.87
Earnings Per Share
1.551.29-0.120.100.320.80
EPS Growth
30.33%---68.27%-60.25%-21.41%

Revenue by Geography

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Northeast China
61.152.6252.7243.3645.1
North China
307.65174.97125.285.8776.87
East China
408.59316.78288.81331.94336.97
South China
251.57209.59186.08202.8211.25
Central China
345.41253.37213.86217.75192.61
Northwest China
58.5641.741.6539.0533.87
Southwest China
88.4687.986.6489.9486.68
Export
159.9163.3924.7912.212.87
Total
1,6811,2001,0201,023996.22

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
476.83470.53527.11597.87785.721,098
Total Debt
515.4228.6888.56842.24790.45680.98
Net Cash (Debt)
-38.56241.93-361.45-244.38-4.72417.47
Net Cash Growth
------41.03%
Net Cash Per Share
-0.181.23-2.18-1.47-0.032.52

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
256.38238.4543.5392.9296.68155.72
Capital Expenditures
-419.83-96.92-194.43-184.31-428.87-600.12
Free Cash Flow
-163.45141.53-150.89-91.39-332.18-444.4
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
34.08%30.86%16.22%20.66%21.78%26.95%
Operating Margin
17.84%16.62%1.53%0.64%5.96%13.58%
Pretax Margin
21.47%17.17%-2.41%1.22%5.54%15.14%
Profit Margin
18.99%15.06%-1.68%1.65%5.15%13.34%
FCF Margin
-9.58%8.42%-12.57%-8.96%-32.48%-44.61%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.6000.3000.1060.2700.3000.331
Dividend Per Share Growth
142.22%181.91%-60.59%-10.00%-9.37%21.11%
Dividend Yield
3.39%1.45%1.06%1.87%1.46%1.16%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
11.3916.51-140.8963.6835.64
Forward PE
15.6720.5320.9630.4420.96-
P/FCF Ratio
-29.53----
PS Ratio
2.082.491.382.323.284.75